Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co/1HnIfvtuRa
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer's disease.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Aug 2023Where it's discussed
-
X / Twitter6 posts
-
News2 articles
-
YouTube1 videos
AI synopsis
What people are saying
Users emphasize the importance of biomarkers like MIF, sTREM1, and sTREM2 in tracking AD, often discussing their levels at various disease stages and their correlation with other clinical measures. The use of terms like 'significant' and 'potential' reflects a mixture of optimism and cautious interest, driven by the article's detailed profiling of inflammatory markers.
Most discussions recognize the significance of the findings, with some explicitly highlighting the potential of these biomarkers for understanding AD progression.
The topic appears highly engaging, with users expressing curiosity about the implications of biomarker dynamics in Alzheimer's disease.
Posts show moderate engagement by referencing specific biomarkers and their roles, indicating thoughtful consideration beyond surface-level reactions.
While some comments hint at the potential clinical impact of these findings, the general tone suggests a developing interest rather than definitive conclusions.
Abstract in brief
- The study found that neuroinflammatory biomarkers like MIF, sTREM1, and sTREM2 show significant changes in their levels across different stages of Alzheimer's disease (AD) and related conditions, indicating their potential as fluid biomarkers for tracking disease progression.
- MIF and sTREM1 levels increase in conditions such as mild cognitive impairment (MCI), AD, and dementia with Lewy bodies (DLB), while sTREM2 levels are notably elevated only in MCI, highlighting their specific roles at different disease stages.
- These inflammatory markers are strongly correlated with other CSF biomarkers of AD, such as pTau, and with clinical measures like MMSE scores, suggesting they could be useful for monitoring neuroinflammatory responses and disease severity in AD.]
Top posts
Most liked on X and BlueskyRT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
RT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
RT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
https://t.co/1TtEQvueHR
All mentions
Dynamic Neuroinflammatory Biomarkers in Alzheimer's Disease Progression
Neuroinflammatory biomarkers like MIF, sTREM1, and sTREM2 exhibit significant changes across Alzheimer's disease stages, indicating their potential as fluid biomarkers for tracking disease progression and severity.
RT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
RT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
RT @Aenoreth: Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co…
https://t.co/1TtEQvueHR
Neuroinflammatory CSF biomarkers MIF, sTREM1, and sTREM2 show dynamic expression profiles in Alzheimer’s disease https://t.co/1HnIfvtuRa